Amarin Corp. (AMRN) Tops Q4 EPS by 6c

Go back to Amarin Corp. (AMRN) Tops Q4 EPS by 6c

Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

March 1, 2022 6:00 AM EST

Go-to-Market Strategy in U.S. to Optimize Provider Engagement and Drive Demand for VASCEPA®

European Expansion Strategy On Track with Reimbursement Negotiations and Launch Preparations for VAZKEPA Underway in Multiple Markets

Plans for Regulatory Filings for Approval of VASCEPA in Several Additional Countries in 2022

Company to Host Conference Call Today at 8:00 a.m. ET

DUBLIN, Ireland and BRIDGEWATER, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced... More